Optimizing BPH Management: Evaluating MIST Options and Key Treatment Considerations

Video content above is prompted by the following:

• What are some of the key differences in the minimally invasive surgical therapy (MIST) options (prostatic urethral lift [PUL], water vapor thermal therapy, robotic waterjet treatment, photoselective vaporization of the prostate)?
  • Please explain factors that may lead you to choose one MIST option over another.
• In terms of patient experience, what are some key differences in MIST options?
  • Please speak of factors such as the need for local/general anesthesia, recovery time, time to symptom relief, preservation of sexual function, durability, etc.
• What clinical and nonclinical factors impact your treatment choice?
  • Please speak to factors such as patient prostate size and symptom severity, common comorbidities, efficacy and durability, recovery time, and possible risks or adverse events.
  • Does a PUL give you more confidence for treating a wide range of patients if the indication for prostate volume is larger (≤100 cc) compared with other options (30-80 cc)?
  • What role does patient preference play in choosing the right treatment?